BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
34 hedge funds and large institutions have $5.29M invested in BRAINSTORM CELL THERAPUTC in 2018 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
26% less capital invested
Capital invested by funds: $7.11M → $5.29M (-$1.82M)
Holders
34
Holding in Top 10
–
Calls
$14K
Puts
–
Top Buyers
| 1 | +$129K | |
| 2 | +$70K | |
| 3 | +$40K | |
| 4 |
EMG
ETF Managers Group
Summit,
New Jersey
|
+$16K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$15.8K |
Top Sellers
| 1 | -$216K | |
| 2 | -$210K | |
| 3 | -$208K | |
| 4 |
Renaissance Technologies
New York
|
-$80.3K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$65K |